Shares of AbbVie Inc. ABBV slid 3.14% to $174.20 Thursday, on what proved to be an all-around dismal trading session for the ...

With this in mind, let us now have a look at the Long-Term Stock Portfolio: 15 Best Stocks for 15 Years.

Gene therapy is an area of intensive research and development in the retina space, with promising prospects and significant challenges. The benefits and pitfalls of gene therapy were discussed by two ...

Sell to hold by James Foord. "I recommend waiting for the next quarter's results and potential tariff resolutions before ...

Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios.

PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors ...

Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

A significant trading signal occurred for AbbVie stock at $164.86, ahead of tariff reversal news. ABBV climbed up to 9.2% ...

(Reuters) - The S&P 500 soared 9.5% on Wednesday for its biggest daily gain since 2008 after U.S. President Donald Trump ...

The pharmaceutical and healthcare sectors were previously viewed as a relative safe haven from the tariff-induced market turmoil. The Health Care Select Sector SPDR exchange-traded fund XLV fell 7.8% ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target ...